ADVANCED MIC.DEV. DL-,01 | 67.68 / -3.34% |
Date/Time | 02/25 / 18:52 |
Chg. / Chg.(%) | -2.34 / -3.34% |
Bid | - |
Ask | - |
Open | 71.22 |
Previous Close | 70.02 |
High | 71.22 |
Low | 67.68 |
Volume [EUR] | 6,157.20 |
Volume [Units] | 90 |
Price fixings | 4 |
ISIN | US0079031078 |
Security | AMD |
Exchange | Hamburg |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
NASDAQ | 82.4200 | ![]() |
54,625,140 |
Cboe US | 82.41 | ![]() |
3,741,846 |
IEX | 82.49 | ![]() |
911,898 |
London Inter.. | 85.07 | ![]() |
94,463 |
TradeGate | 67.820 | ![]() |
47,378 |
Xetra | 69.30 | ![]() |
17,273 |
Moscow | 6,193.00 | 12,602 | |
Stuttgart | 67.580 | ![]() |
3,256 |
gettex | 68.000 | ![]() |
2,225 |
Frankfurt | 68.0000 | ![]() |
1,586 |
Borsa Italia.. | 69.60 | ![]() |
1,512 |
Vienna Globa.. | 69.42 | ![]() |
1,117 |
Düsseldorf | 67.77 | ![]() |
643 |
Hamburg | 67.68 | ![]() |
90 |
Berlin | 70.92 | ![]() |
61 |
München | 70.27 | ![]() |
36 |
Hannover | 71.76 | ![]() |
10 |
Lang & Schwa.. | 67.370 | ![]() |
|
Mexico | 1,770.00 | ![]() |
31,705 |
Borsa Italia.. | 70.86 | ![]() |
2 |
News
- Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results
02/25/2021 / 22:01 - GlobeNewswire - Akari Therapeutics Presents New Preclinical Data Highlighting Potential of Long-Acting PASylated Nomacopan to Treat Retinal Diseases, Including Age-Related Macular Degeneration (AMD) and Uveitis
02/25/2021 / 15:07 - GlobeNewswire - Opthea Finalizes Study Designs and Start-up Activities for Phase 3 Pivotal Clinical Trials of OPT-302 in Wet AMD
02/24/2021 / 11:30 - GlobeNewswire - DigitalOcean Launches Premium Droplets
02/23/2021 / 17:30 - GlobeNewswire - AsclepiX Therapeutics partners with Notal Vision on Home OCT remote monitoring in DME and AMD clinical trials
02/23/2021 / 14:00 - GlobeNewswire